Research: A Fulgent lab technician uses a multichannel pipette to dispense a reagent. El Monte-based genetic testing and clinical lab analysis company Fulgent Genetics Inc., which rode the Covid ...
The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...
(RTTNews) - Myriad Genetics, Inc. (MYGN), a genetic testing and precision medicine company, on Wednesday announced its groundbreaking study results on the Prequel Prenatal Screen with AMPLIFY ...
Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products Fast-growing SneakPeek test has helped 750,000 parents learn baby’s gender from home – earliest ...
BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY ® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...
As we move towards more personalized medicine, the importance of precision diagnostics is increasing. Yet, most molecular diagnostics testing remains complex, inefficient, and out of reach for many ...
Expecting mothers typically opt for prenatal genetic testing during their first and third trimesters. Performed with a sample of the mother's blood, this test looks for fetal aneuploidy, an abnormal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback